STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Clinical trial NCT06626256 · WITHDRAWN

Trial details

NCT number: NCT06626256
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Cervical Carcinoma Locally Advanced Colorectal Carcinoma Locally Advanced Malignant Solid Neoplasm Locally Advanced Melanoma Locally Advanced Pancreatic Ductal Adenocarcinoma Locally Advanced Renal Cell Carcinoma Metastatic Cervical Carcinoma Metastatic Colorectal Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Melanoma Metastatic Pancreatic Ductal Adenocarcinoma Metastatic Renal Cell Carcinoma

Start date: 2025-12-05
Primary completion: 2027-10-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.